Effect of 100% Orange Juice on Food Intake and Glycemic Response in Adults
Effect of 100% Orange Juice Intake on Subjective Appetite, Food Intake, Glycemic Response and Subjective Mood in Healthy Adults
1 other identifier
interventional
36
1 country
1
Brief Summary
The purpose of this study is to determine the effects of 100% orange juice on short-term food intake (FI), satiety, post-prandial glycemia and mood in healthy adults. We hypothesize that the consumption of 100% orange juice in the pre-meal environment will improve satiety signals and mood, and suppress FI through its effect on post-prandial glycemia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Oct 2021
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 11, 2021
CompletedFirst Posted
Study publicly available on registry
August 19, 2021
CompletedStudy Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 22, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2022
CompletedMarch 6, 2023
March 1, 2023
1.2 years
August 11, 2021
March 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change from baseline glycemic response (acute phase)
Blood glucose (mmol/L). Three drops of blood from the finger will be collected at each time point using a single-use, auto-disabling lancet device and sodium fluoride/potassium oxalate capillary blood collection tubes. Blood glucose will be measured using a YSI 2900D Biochemistry Analyzer (YSI Inc., Yellow Springs, OH).
Collected at baseline (0 minutes), 15 minutes, 30 minutes, 45 minutes, and 60 minutes post-treatment consumption
Rest-of-day blood glucose concentrations
Blood glucose (mmol/L). Rest-of-day blood glucose concentrations will be determined using a Dexcom G6 CGM system.
Continuous measurements for 24 hours post-treatment consumption
Ad libitum food intake
Lunch pizza meal. Food intake will be determined by weighing the meal before and after serving. The net weight of the test meal will be converted to calories.
At 60 minutes post-treatment consumption
Secondary Outcomes (4)
Change from baseline subjective appetite
Collected at baseline (0 minutes), 15 minutes, 30 minutes, 45 minutes, and 60 minutes post-treatment consumption
Change from baseline subjective emotions and mood
Collected at baseline (0 minutes), 15 minutes, 30 minutes, 45 minutes, and 60 minutes post-treatment consumption
Rest-of-the-day food intake
For the rest of the day following test session completion (1 day)
Rest-of-the-day physical activity
For the rest of the day following test session completion (1 day)
Study Arms (3)
Orange juice
EXPERIMENTALTreatment beverage
Orange flavoured drink
EXPERIMENTALTreatment beverage
Water
EXPERIMENTALTreatment beverage
Interventions
Matched for volume (240 mL/ 8 oz) of other test beverages. 100% orange juice.
Matched for volume (240 mL/ 8 oz) of other test beverages. Orange flavoured drink
Eligibility Criteria
You may qualify if:
- aged 18-45 years;
- within the healthy body mass index (BMI) range for adults of 18.5-24.9 kg/m2.
You may not qualify if:
- individuals who are dieting;
- restrained eaters;
- breakfast skippers;
- those who dislike breakfast or lunch treatment foods;
- those taking medication;
- individuals with any metabolic disorders or significant weight fluctuations.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre for Urban Innovation (CUI-109), School of Nutrition, Ryerson University
Toronto, Ontario, M5B 2K3, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nick Bellissimo, PhD
Toronto Metropolitan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 11, 2021
First Posted
August 19, 2021
Study Start
October 1, 2021
Primary Completion
December 22, 2022
Study Completion
December 22, 2022
Last Updated
March 6, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share